MEZENKİMAL TÜMÖRLERİN İMMÜNHİSTOKİMYASAL OLARAK EPİTELYAL - MEZENKİMAL TRANSİZYON (EMT) VE MEZENKİMAL - EPİTEL TRANSİZYON (MET) AÇISINDAN DEĞERLENDİRİLMESİ
xmlui.mirage2.itemSummaryView.MetaDataShow full item record
AIM: To investigate immunohistochemical expression of EMT/MET and associated markers among mesenchymal tumors together with their potential influence on biological characteristics of these tumors. MATERIALS AND METHODS: Mesenchymal tumor cases (n=527) and also carcinoma (n=28) and malignant melanoma (n=18) control groups were selected for our study. Sections from tissue microarrays of 3-4 mm diameter, were immunohistochemically stained with SLUG, TWIST1, E-cadherin, ZEB1, Beta-catenin, P-cadherin, TCF15 (PARAXIS) and ALDH1 by Leica Autostainer. Cases were grouped as METhigh, METlow and METneg according to their staining patterns with E-cadherin, SLUG and TWIST1. Differentiated and dedifferentiated foci of dedifferentiated liposarcomas (n=16), also primary and metastatic foci of sarcomas with nodal metasis (n=7) were compared. RESULTS: Mesenchymal tumors were classified as METhigh (%19), METlow (%71,1) and METneg (%9,8), tendency towards epithelial transition was dominantly present. P-cadherin expression was found in %8,9 of mesenchymal tumors and was present nearly only in sarcomas. %33,5 of cases were positive with ALDH1 with prominent expression among nerve sheath tumors (%73,7). Nuclear staining with beta-catenin was rare (%4,4) and membranous staining was %23,3. TCF15 expression was found in %13,4 of cases. No significant difference was noted between the differentiated and dedifferentiated foci of dedifferentiated liposarcomas or primary and metastatic foci of sarcomas with nodal metastasis in terms of any markers (p>0,05). ALDH1 is helpful in distinction between MPNST and monophasic synovial sarcoma (%59,1 vs. %9,5); also DSRCT and Ewing’s sarcoma (%75 vs. %0). CONCLUSIONS: MET tendency is a frequent finding among mesenchymal tumors. Dedifferentiation or nodal metasis were unrelated to MET. Presence of P-cadherin only in sarcomas set us thinking on its potential role in tumor progression. Markers such as ALDH1 and E-cadherin could be useful in diffential diagnoses of mesenchymal neoplasms.
The following license files are associated with this item:
Showing items related by title, author, creator and subject.
Kemik İliği Yağ Tabakasından Elde Edilen Mezenkimal Kök Hücrelerin Karakterizasyonu ve Subkutan Yağ ve Kemik İliği Kökenli Mezenkimal Kök Hücreleri ile Karşılaştırılması Tonyalı, Gülsena (Sağlık Bilimleri Enstitüsü, 2020-09)Bone marrow adipose tissue (BMAT) has different properties than other adipose tissues. Recent studies have shown the effects of bone marrow adipose tissue on development / progression of acute myeloblastic leukemia (AML), ...
DALKIRAN, Dilara (Sağlık Bilimleri Enstitüsü, 2018)Mesenchymal Stem Cells (MSC) have therapeutic importance because of their multipotency and immune modulation potentials. Erythropoietin is responsible for erytropoesis. However, EPO treatment of cells including mesenchymal ...
Hücreden Arındırılmış Omentum Biyoçatının Mezenkimal Kök Hücre ve Trombositten Zengin Plazma ile Kombinasyonlarının Kritik Kemik Defekti İyileşmesine Etkisi: Bir sıçan Modeli. Emet, Abdülsamet (Tıp Fakültesi, 2018)Critical sized bone defect treatments have high-costed and long time needing is still a major clinical concern on orthopaedic surgery. Despite there is a lot of treatment modalities on literature, we are also looking for ...